Cleared Traditional

K982591 - DADE TRU-LIQUID CARDIAC CONTROL

K982591 is the FDA 510(k) clearance for DADE TRU-LIQUID CARDIAC CONTROL by Dade Behring, Inc.. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 12-day FDA review.

K982591 · Dade Behring, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1998
Decision
12d
Days
Class 1
Risk

K982591 is an FDA 510(k) clearance for the DADE TRU-LIQUID CARDIAC CONTROL. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Dade Behring, Inc. (Miami, US). The FDA issued a Cleared decision on August 5, 1998 after a review of 12 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Dade Behring, Inc. devices

Submission Details

510(k) Number K982591 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 24, 1998
Decision Date August 05, 1998
Days to Decision 12 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 88d · This submission: 12d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 301
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K982591.
CARDIAC MARKER CONTROL MODULE, MODEL CCCM
K983971 · Diagnostic Products Corp. · Nov 1998
ARCHITECT TESTOSTERONE MASTERCHECK, MODEL 6C28-05
K983578 · Bio-Rad · Nov 1998
B2-MICROGLOBULIN CONTROL SET SERUM
K982471 · Boehringer Mannheim Corp. · Aug 1998
VIGIL HEMOGLOBIN (HBALC) CONTROLS
K982022 · Beckman Coulter, Inc. · Jul 1998
ACCESS AFP QC ON THE ACCESS IMMUNOASSAY ANALYZER, MODEL NUMBER 33219
K981864 · Beckman Coulter, Inc. · Jun 1998
DADE TRU-LIQUID CARDIAC CONTROL
K981622 · Dade Behring, Inc. · Jun 1998